Drug
AZD1236
AZD1236 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_1
1
20%
Ph early_phase_1
1
20%
Ph phase_2
3
60%
Phase Distribution
2
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 23 (60.0%)
Trials by Status
completed480%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
completedearly_phase_1
Imaging FIB ONE in the Human Lung Using Endomicroscopy
NCT02604862
completedphase_2
A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758706
completedphase_2
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758459
completedphase_1
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00767052
withdrawnphase_2
Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
NCT00812045
Clinical Trials (5)
Showing 5 of 5 trials
NCT02604862Early Phase 1
Imaging FIB ONE in the Human Lung Using Endomicroscopy
NCT00758706Phase 2
A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758459Phase 2
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00767052Phase 1
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00812045Phase 2
Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5